30 Jul 2026 · 12:25 IST
L24297MH2020PLC338592
Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com 30th July, 2026 BSE Limited P.J. Towers, Dalal Street, Fort, Mumbai- 400 001 BSE scrip code: 543635 National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051 NSE symbol: PPLPHARMA Sub: Proceedings and Voting Results of the 6th Annual General Meeting (‘AGM’) of Piramal Pharma Limited (‘the Company’) Dear Sir / Madam, This is to inform that the 6th AGM of the Members of the Company was held today, Thursday, 30th July, 2026 at 3:00 p.m. (IST) through Video Conferencing / Other Audio Visual Means for transacting the business(es) mentioned in the Notice dated 5th June, 2026 convening the AGM (‘Notice of the AGM’). All the resolutions proposed in the Notice of the AGM have been passed with requisite majority. In this regard, please find enclosed the following: 1. Summary of the proceedings of the AGM, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), attached as Annexure-1; and 2. Consolidated Report of the Scrutinizer, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, along with voting results of the business transacted at the AGM, pursuant to Regulation 44(3) of the SEBI Listing Regulations, attached as Annexure-2. This is for your information and records. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Encl: a/a SIGN Maneesh Sharma Digitally signed by Maneesh Sharma Date: 2026.07.30 19:31:35 +05'30' Piramal Pharma Limited
L24297MH2020PLC338592
Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com Annexure-1 Summary of proceedings of the 6th Annual General Meeting of Piramal Pharma Limited held on 30th July, 2026 The 6th Annual General Meeting (‘AGM’) of Piramal Pharma Limited (‘the Company’) was held today, Thursday, 30th July, 2026 at 3:00 p.m. (IST) through Video Conferencing (‘VC’)/ Other Audio Visual Means (‘OAVM’) in accordance with circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). Ms. Nandini Piramal, Chairperson of the Company, chaired the meeting. The requisite quorum being present, the Chairperson called the Meeting to order. The Chairperson introduced all the Board Members along with the Chairpersons of the Audit Committee, Stakeholders Relationship Committee, Nomination and Remuneration Committee, who were present at the Meeting. The Chairperson informed that, apart from the Board Members, the key executives and representatives of the Auditors were also present at the AGM. The Members were informed that live proceedings of the AGM were being webcast live on the e-voting website of National Securities Depository Limited (‘NSDL’). With the consent of the Members present, the Notice convening the 6th AGM was taken as read. The Members were informed that as there were no qualifications in the Audit Report, the notice was not required to be read. The Members were also informed that the relevant Statutory Registers and documents were available for inspection electronically during the Meeting. The Members were also informed that in accordance with the provisions of Section 108 of the Companies Act, 2013 (‘the Act’) read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided remote e-voting facility to its Members for casting of the votes through electronic means. The remote e-voting commenced at 9:00 a.m. on Monday, 27th July, 2026 and ended at 5:00 p.m. on Wednesday, 29th July, 2026. The facility for e-voting was also made available during the AGM, in accordance with the provisions on e-voting framed under the Act, for Members who had not cast their vote through remote e-voting. The Members were informed that Mr. Bhaskar Upadhyay, Practising Company Secretary, failing him Mr. Bharat R. Upadhyay, Practising Company Secretary of N L Bhatia & Associates, Practising Company Secretaries, was appointed as the Scrutinizer to scrutinize the process of remote e-voting and e-voting during the AGM. Piramal Pharma Limited
L24297MH2020PLC338592
Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com The Chairperson then apprised the Members regarding the performance of the Company and key highlights of FY 2025-26. Thereafter, the following items of business as set out in the Notice convening the 6th AGM were transacted, and the resolutions relating thereto were put to vote and duly passed by the Members with the requisite majority: No. Resolutions Type of resolution
1. Adoption of Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon Ordinary 2. Re-appointment of Mr. Peter DeYoung (DIN: 07152550), who retires by rotation and being eligible, offers himself for re- appointment Ordinary 3. Re-appointment of Ms. Nathalie Leitch (DIN: 09557042), who retires by rotation and being eligible, offers herself for re- appointment Ordinary
4. Re-appointment of Mr. Peter DeYoung (DIN: 07152550) as Whole-Time Director, designated as Executive Director of the Company Special 5. Re-appointment of Ms. Nandini Piramal (DIN: 00286092) as Whole-Time Director, designated as Executive Director and Chairperson of the Company Special 6. Re-appointment of Mr. Sridhar Gorthi (DIN: 00035824) as an Independent Director of the Company Special 7. Re-appointment of Mr. Peter Stevenson (DIN: 09544706) as an Independent Director of the Company Special 8. Ratification of remuneration payable to Cost Auditors for the Financial Year 2026-27 Ordinary 9. Issue of Non-Convertible Debentures on Private Placement Basis Special 10. Creation of pledge or any other security or encumbrance over the shareholding of the Company in its material subsidiaries and/ or the assets of such material subsidiaries, and enabling approval for related disposal in the event of enforcement of such pledge, security or encumbrance Special The Chairperson then invited the Members who had registered themselves as speakers to express their views, ask questions and seek clarifications on the operations and financial performance of the Company and the resolutions proposed. The Chairperson responded to the queries raised by the Members. Piramal Pharma Limited
L24297MH2020PLC338592
Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com The Members were informed that the voting results along with the consolidated report of the Scrutinizer would be disseminated to the Stock Exchanges and would also be placed on the website of the Company and NSDL, within the prescribed statutory timelines. The Meeting concluded at 4:26 p.m., after remaining open for 15 minutes to enable completion of the e-voting process. NL BHATIA & ASSOCIATES PRACTISING COMPANY SECRETARIES Scrutinizer's Report Tel. : 91-022-25100718 Tel. : 91-022-2510 0698
navnitlb@hotmail.com brupadhyay @hotmail.com
www.nlba.in [Pursuant to Section 108 of the Companies Act, 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration) Rules, 2014 read with amendments made thereto] To, Ms. Nandini Piramal, Chairperson, Piramal Pharma Limited, Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai-400070 Sub: Consolidated Report of the Scrutinizer on the remote e-voting and e-voting at the Annual General Meeting of Piramal Pharma Limited convened on Thursday, 30th July, 2026 at 3:00 p.m. (1ST) through Video Conferencing / Other Audio Visual Means Dear Ma'am, I, Mr. Bhaskar Upadhyay, Practising Company Secretary (Membership No. FCS 8663/C.P No. 9625), partner of N L Bhatia & Associates, Practising Company Secretaries, have been appointed as the Scrutinizer by the Board of Directors of Piramal Pharma Limited (the 'Company') for the purpose of conducting and scrutinizing the remote e-voting as well as e-voting process at the 6th Annual General Meeting ('AGM') held on Thursday, 30th July, 2026 at 3:00 P.M. Indian Standard Time ('IST') through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM') on the resolutions contained in the Notice dated 5th June, 2026 convening the said AGM ('the AGM Notice') and ascertaining the requisite majority as per the provisions of Section 108 of the Companies Act, 2013 ('the Act') read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and amendments made thereto. 1. I present the Scrutinizer's Report as follows: The compliance with the provisions of the Act and the Rules made thereunder and General Circular Nos. 14/2020, 17/2020, 20/2020, 02/2021, 21/2021, 02/2022, 10/2022, 09/2023, 09/2024 and 03/2025 dated 8th April, 2020, 13th April, 2020, 5th May, 2020, 13th January, 2021, 14th December, 2021, 5th May, 2022, 28th December, 2022, 25 th September, 2023, 19th September, 2024 and 22nd September, 2025 respectively issued by Ministry of Corporate Affairs ('MCA') (hereinafter referred to as 'MCA Circulars') relating to remote e- voting and e-voting during the AGM on the resolutions contained in the AGM Notice is the responsibility of the Management. My responsibility as a Scrutinizer was to ensure that the voting process was conducted in a fair and transparent manner and submit a consolidated Scrutinizer's Report on the voting on the resolutions based on the reports generated from the electronic voting system provided by the National Securities Depository Limited ('NSDL'), the agency appointed to provide remote e-voting facilities and voting at the AGM conducted by the same e-voting system ofNSDL which was used during remote e-voting. 2. Further to above, I submit the report as under: Pa e 1 of 15 507, Skyline Wealth Space, 5th Floor, C2 Wing, Skyline Oasis Complex, Premier Road, Near Vidyavihar Station, Ghatkopar - West, Mumbai- 400086. Annexure-2 Continuation Sheet 2.1 The Company had provided the remote e-voting facility through NSDL's website www.evoting.nsdl.com. The Company had uploaded the AGM Notice containing the items of businesses to be transacted at the AGM on the website of the Company and also on website of the Stock Exchanges viz. BSE Limited and the National Stock Exchange of India Limited and NSDL's website for perusal by those Members who may want to access the same. 2.2 The AGM Notice was sent by electronic mode to those Members whose email addresses were registered with the Company/ Depository Participant(s) The AGM Notice contained the detailed procedure to be followed by the Members who were desirous of casting their votes electronically as provided under Rule 20 of the Companies (Management and Administration) Rules, 2014 read with amendments made thereto. 2.3 The Company has also sent physical letters under Regulation 36(l)(b) to those shareholders whose email addresses were not registered with the Company/ Depository Participant(s)/ MUFG Intime India Private Limited (formerly Link Intime India Private Limited), Registrar and Share Transfer Agent of the Company. 2.4 The Company published an advertisement in Business Standard - All Editions in English Language and in Mumbai Lakshadeep - Mumbai edition in Marathi Language on Friday 19th June, 2026, as required under clause 3 (A) (IV) of the General Circular No. 20/2020 issued by MCA dated 5th May, 2020. 2.5 The Company published an advertisement in Business Standard - All Editions in English Language and in Mumbai Lakshadeep - Mumbai edition in Marathi Language on Saturday 4th July, 2026 providing the details of the dispatch of Notice, details of cut-off date and e-voting facilities provided by the Company, as required under Rule 20 of Companies (Management and Administration) Rules, 2014. 2.6 The voting rights of Members have been reckoned in proportion to their shares held in the paid-up equity share capital of the Company as on the close of business hours on Thursday, 23rd July, 2026. 2.7 The remote e-voting commenced on Monday, 27th July, 2026 at 9:00 a.m. (1ST) and concluded on Wednesday, 29th July, 2026 at 5:00 p.m. (1ST) 2.8 At the AGM, the Company Secretary, announced that the Members present at the AGM through VC/ OAVM and who had not cast their vote by remote e-voting, could exercise their voting rights through e-voting using the same e-voting system of NSDL which was used during remote e-voting. Thereafter, on completion of voting by the Members during the AGM, the votes cast by the Members during the AGM and the votes under remote e-voting were unblocked and the reports were downloaded from the NSDL e-voting platform. 3. My consolidated report is as under on the result of the remote e-voting and e-voting during the AGM in respect of the said resolutions. Page 2 of25 N L Bhatia & Associates Continuation Sheet Item No. 1: As an Ordinary Resolution: To receive, consider and adopt the Audited Financial Statements (Standalone and consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 935 99,24,89,842 99.8320 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 24 16,70,281 0.1680 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 3 of25 N L Bhatia & Associates Continuation Sheet Item No. 2: As an Ordinary Resolution: To appoint a Director in place of Mr. Peter De Young (DIN: 07152550), who retires by rotation and being eligible, offers himself for re-appointment: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 907 99,34,97,552 99.9071 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 59 9,24,214 0.0929 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 4 of25 N L Bhatia & Associates Continuation Sheet Item No. 3: As an Ordinary Resolution: To appoint a Director in place of Ms. Nathalie Leitch (DIN: 09557042), who retires by rotation and being eligible, offers herself for re-appointment: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 907 99,34,85,664 99.9059 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 59 9,36,102 0.0941 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 5 of25 N L Bhatia & Associates Continuation Sheet Item No. 4: As a Special Resolution: Re-appointment of Mr. Peter DeYoung (DIN: 07152550) as Whole-Time Director, designated as Executive Director of the Company: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 816 92, 12,37,904 92.6406 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 149 7,31,83,612 7.3594 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 6 of25 N L Bhatia & Associates Continuation Sheet Item No. 5: As a Special Resolution: Re-appointment of Ms. Nandini Piramal (DIN: 00286092) as Whole-Time Director, designated as Executive Director and Chairperson of the Company: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 803 90,02,03,351 90.5253 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 159 9,42,18,255 9.4747 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 7 of25 N L Bhatia & Associates Continuation Sheet Item No. 6: As a Special Resolution: Re-appointment of Mr. Sridhar Gorthi (DIN: 00035824) as an Independent Director of the Company: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 767 91,07,68,243 91.5877 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 194 8,36,53,343 8.4123 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 8 of25 N L Bhatia & Associates Continuation Sheet Item No. 7: As a Special Resolution: Re-appointment of Mr. Peter Stevenson (DIN: 09544706) as an Independent Director of the Company: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 908 99,41,22,815 99.9699 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 52 2,98,901 0.0301 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 9 of25 N L Bhatia & Associates Continuation Sheet Item No. 8: As an Ordinary Resolution: Ratification of remuneration payable to Cost Auditors for the Financial Year 2026-27: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 927 99,42,22,158 99.9799 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 33 1,99,508 0.0201 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 10 of 25 N L Bhatia & Associates Continuation Sheet Item No. 9: As a Special Resolution: Issue of Non-Convertible Debentures on Private Placement Basis: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 902 98,93,97,431 99.4950 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 63 50,21,825 0.5050 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 11 of 25 N L Bhatia & Associates Continuation Sheet Item No. 10: As a Special Resolution: Creation of pledge or any other security or encumbrance over the shareholding of the Company in its material subsidiaries and/ or the assets of such material subsidiaries, and enabling approval for related disposal in the event of enforcement of such pledge, security or encumbrance: (i) Voted in favour of the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 820 95,63,85,603 96.1751 (ii) Voted against the resolution: Number of members Number of votes cast % of total number of voted valid votes cast 141 3,80,35,874 3.8249 (iii) Invalid votes: Number of members whose votes were Number of invalid votes cast by declared invalid them - - Page 12 of 25 N L Bhatia & Associates Continuation Sheet The results in the format under Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given as an Annexure. Based on the foregoing, the Resolution Nos. 1 to 10 have been passed with the requisite majority on the date of the AGM i.e. Thursday 30th July, 2026 Thanking you, Yours faithfully, Mr. Bhaskar B. Upadhyay (FCS-8663) Practising Company Secretary, Scrutinizer for Remote E-voting and E-voting during the AGM UDIN: F008663H000984110
Mumbai Date:- July 30, 2026 N L Bhatia & Associates Countersigned by Maneesh Sharma Company Secretary Page 13 of 25 SIGN Maneesh Sharma Digitally signed by Maneesh Sharma Date: 2026.07.30 19:32:05 +05'30' Continuation Sheet Scrutinizer Details Name of the Scrutinizer Bhaskar Upadhyay Firms Name NL Bhatia & Associates Qualification cs Membership Number FCS 8663 Date of Board Meeting in which appointed 28-04-2026 Date of Issuance of Report to the company 30-07-2026 Page 14 of 25 N L Bhatia & Associates Continuation Sheet Voting results Record date 23-07-2026 Total number of shareholders on record date 481440 No. of shareholders present in the meeting either in person or through proxy a) Promoters and Promoter group 0 b) Public 0 No. of shareholders attended the meeting through video conferencing a) Promoters and Promoter group 15 b) Public 86 No. of resolution passed in the meeting 10 Disclosure of notes on voting results Add Notes Page 15 of 25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited 1 - Receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the
Ordinary Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon. Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No.of Polled on No. of No. of % of Votes in % of Votes Voting No.of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2)/[1]}* 100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269145264 75.7180 267482050 1663214 99.3820 0.6180 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269145264 75.7180 267482050 1663214 99.3820 0.6180 E-Voting 261695123 51.0559 261688056 7067 99.9973 0.0027 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695123 51.0559 261688056 7067 99.9973 0.0027 Total 1331348130 994160123 74.6732 992489842 1670281 99.8320 0.1680 Page 16 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited 2 - Appointment of Director in place of Mr. Peter DeYoung (DIN: 07152550), who retires by rotation
Ordinary and being eligible, offers himself for re-appointment. Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No. of No. of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 268505970 900847 99.6656 0.3344 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 268505970 900847 99.6656 0.3344 E-Voting 261695213 51.0559 261671846 23367 99.9911 0.0089 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695213 51.0559 261671846 23367 99.9911 0.0089 Total 1331348130 994421766 74.6928 993497552 924214 99.9071 0.0929 Page 17 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Ordinary 3 - Appointment of Director in place of Ms. Nathalie Leitch (DIN: 09557042), who retires by rotation and being eligible, offers herself for re-appointment. Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No. of No. of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 268491305 915512 99.6602 0.3398 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 268491305 915512 99.6602 0.3398 E-Voting 261695213 51.0559 261674623 20590 99.9921 0.0079 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695213 51.0559 261674623 20590 99.9921 0.0079 Total 1331348130 994421766 74.6928 993485664 936102 99.9059 0.0941 Page 18 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Special 4 - Re-appointment of Mr. Peter DeYoung (DIN: 07152550) as Whole-Time Director, designated as Executive Director of the Company Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No.of No.of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 196252917 73153900 72.8463 27.1537 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 196252917 73153900 72.8463 27.1537 E-Voting 261694963 51.0558 261665251 29712 99.9886 0.0114 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261694963 51.0558 261665251 29712 99.9886 0.0114 Total 1331348130 994421516 74.6928 921237904 73183612 92.6406 7.3594 Page 19 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Special 5 - Re-appointment of Ms. Nandini Piramal (DIN: 00286092) as Whole-Time Director, designated as Executive Director and Chairperson of the Company Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No.of No.of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 175213644 94193173 65.0368 34.9632 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 175213644 94193173 65.0368 34.9632 E-Voting 261695053 51.0559 261669971 25082 99.9904 0.0096 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695053 51.0559 261669971 25082 99.9904 0.0096 Total 1331348130 994421606 74.6928 900203351 94218255 90.5253 9.4747 Page 20 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Special 6- Re-appointment of Mr. Sridhar Gorthi (DIN: 00035824) as an Independent Director of the Company Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No.of No.of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 185793303 83613514 68.9638 31.0362 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 185793303 83613514 68.9638 31.0362 E-Voting 261695033 51.0559 261655204 39829 99.9848 0.0152 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695033 51.0559 261655204 39829 99.9848 0.0152 Total 1331348130 994421586 74.6928 910768243 83653343 91.5877 8.4123 Page 21 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Special 7 - Re-appointment of Mr. Peter Stevenson (DIN: 09544706) as an Independent Director of the Company Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No. of No. of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 269135128 271689 99.8992 0.1008 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 269135128 271689 99.8992 0.1008 E-Voting 261695163 51.0559 261667951 27212 99.9896 0.0104 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695163 51.0559 261667951 27212 99.9896 0.0104 Total 1331348130 994421716 74.6928 994122815 298901 99.9699 0.0301 Page 22 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Ordinary 8 - Ratification of remuneration payable to Cost Auditors for the Financial Year 2026-27 Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No. of No. of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 269225219 181598 99.9326 0.0674 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 269225219 181598 99.9326 0.0674 E-Voting 261695113 51.0559 261677203 17910 99.9932 0.0068 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261695113 51.0559 261677203 17910 99.9932 0.0068 Total 1331348130 994421666 74.6928 994222158 199508 99.9799 0.0201 Page 23 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited
Special 9 - Issue of Non-Convertible Debentures on Private Placement Basis Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No.of Polled on No. of No.of % of Votes in % of Votes Voting No.of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2)/[1]}* 100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 264405454 5001363 98.1436 1.8564 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 264405454 5001363 98.1436 1.8564 E-Voting 261692703 51.0554 261672241 20462 99.9922 0.0078 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261692703 51.0554 261672241 20462 99.9922 0.0078 Total 1331348130 994419256 74.6927 989397431 5021825 99.4950 0.5050 Page 24 of25 N L Bhatia & Associates Continuation Sheet Piramal Pharma Limited 10 - Creation of pledge or any other security or encumbrance over the shareholding of the Company in
Special its material subsidiaries and/ or the assets of such material subsidiaries, and enabling approval for related disposal in the event of enforcement of such pledge, security or encumbrance Whether promoter/ promoter group are interested No in the agenda/resolution? % of Votes Mode of No. of Polled on No.of No.of % of Votes in % of Votes Voting No. of votes outstanding Votes-in Votes- favour on votes against on votes shares held polled shares favour Against polled polled Category [1] [2] [3]={[2]/[1]}*100 [4) [5] [6]={[4]/[2]}*100 [7)={[5)/[2]}* 100 E-Voting 463319736 99.9989 463319736 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter Group Postal 463324672 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 463319736 99.9989 463319736 0 100.0000 0.0000 E-Voting 269406817 75.7916 231466918 37939899 85.9172 14.0828 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions Postal 355457387 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 269406817 75.7916 231466918 37939899 85.9172 14.0828 E-Voting 261694924 51.0558 261598949 95975 99.9633 0.0367 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 Institutions Postal 512566071 Ballot 0 0.0000 0 0 0.0000 0.0000 Total 261694924 51.0558 261598949 95975 99.9633 0.0367 Total 1331348130 994421477 74.6928 956385603 38035874 96.1751 3.8249 Page 25 of25 N L Bhatia & Associates